Skip to main content
. 2022 Jul 22;13:911164. doi: 10.3389/fimmu.2022.911164

Figure 4.

Figure 4

Neutralizing antibody responses in mice vaccinated by dTK-S. (A) Pseudovirus neutralization titers were determined for sera collected 2 weeks after dTK-S boost immunization. A 50% reduction relative to the uninfected control wells was shown as pseudovirus NT50. (B) Neutralization activities of the sera from the second dose of dTK-S vaccination against rVSV-eGFP-SARS-CoV-2. (C) VLP neutralization activities of sera from the second dose of dTK-S vaccination. (D) Neutralization activities of the sera from the second dose of dTK-S vaccination against SARS-CoV-2. (E) Neutralization activities of sera from the second dose of dTK-S vaccination for pseudoviruses carrying spike proteins of the SARS-CoV-2 Wuhan strain (WH-S) B.1.351 or B.1.617.2. (F) Neutralization activities of sera from the immunized mice for pseudoviruses carrying spike protein of the SARS-CoV-2 Wuhan strain (WH-S), B.1.351, or carrying single mutations K417N, E484K, N501Y, or D614G. (G) Neutralization activities of sera from the second dose of dTK-S vaccination for pseudoviruses carrying spike proteins of the SARS-CoV-2 Wuhan strain (WH-S) or B.1.1.529. Dotted lines indicate the lower limit of detection (LLOD). Animals with a response at or below the LLOD were put on LLOD. Statistical differences as determined by Student’s t-tests are indicated by asterisks; *p < 0.05, **p < 0.01; ***p < 0.001. dTK-S, vaccinia virus-expressing spike protein; VLP, virus-like particle.